Report cover image

Rare Disease ?Pipeline Analysis ?Landscape in 2023

Publisher GlobalData
Published Feb 28, 2024
Length 29 Pages
SKU # GBDT18691066

Description

Rare Disease ​Pipeline Analysis ​Landscape in 2023


Summary

This report investigates the Rare Disease ​Pipeline Analysis ​Landscape in 2023 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot to prioritize these trends within your sector.

Scope

This 29-page report gives important, expert insight you won’t find in any other source. 12 figures throughout the report illustrate major points and trends in Rare Disease. This report is required reading for -
  • Investors that want to understand current rare disease trends impacting the biopharmaceutical industry as well as identifying companies to invest in
  • Companies that are interested in seeing the extent and impact of rare diseases trends and how best to pivot towards it.
  • Large pharma companies with investment groups or BD teams looking to see which rare disease led biopharmaceutical companies lead the industry currently and what their focuses are on
Reasons to Buy

Insights on Drug Development Landscape​
Insights on Leading key companies and sponsors ​
Insights on Upcoming drug launches​
Insights on Innovation Landscape​
Insights on Patent grant trends​
Insights on Leading companies by patents​
Insights on Dealmaking trends ​
Insights on Orphan drug designation approvals over time​

Table of Contents

29 Pages
Rare Disease Overview
Regulatory Reforms
Drug Development Landscape
Drugs by therapy area
Drugs by indication
Therapy area sales growth
Leading key companies and sponsors
Upcoming drug launches
Innovation Landscape
Patent grant trends
Leading companies by patents
Dealmaking trends
Orphan drug designation approvals over time
AI Industry Trends
Most Active Companies in AI Development
Therapy Areas by Deal Value and Volume
Key Findings
Appendix
Abbreviations
Methodology
Related Reports
About the Authors
About GlobalData
Contact Us
List of Figures
Therapy Area by Pipeline Drugs 2023
Indications by Pipeline Drugs
Therapy Area Forecast Annual Sales Growth (2023 to 2029)
Drugs by Highest Development Stage
Leading Companies by Drugs in Late-Stage Development
Top Clinical Trial Sponsors in 2024
Top 10 Drug Launches by Sales
Rare Disease Patents Granted Over Time (2018 to 2022)
Leading Patent Assignees (2016 to 2022)
Rare Disease Deals Over Time (2013 to 2022)
Deals by Therapy Area (2018 to 2022)
Orphan Drug Designation Approvals Over Time (2013 to 2022)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us